This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Enabling a Phase I Clinical Trial of a Novel CAR-T Cell Therapy for Ovarian Cancer
Investigating the proteome and secretome of ovarian cancer to inform early detection and treatment
Uncovering targetable interactions of ovarian cancer cells
Uncovering novel metabolic regulators of T cell function
Exploring the role of PARG in DNA repair and cancer
Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer
A new approach to sustained, local, immunotherapy for ovarian cancer
Ovarian Cancer in Nova Scotian patients: Studying tumour genetics and immune cell interactions over time to unlock new treatment opportunities
Testing a novel treatment target in clear cell ovarian cancer
Anti-estrogen therapy and ER/PR expression in low-grade serous ovarian cancer
